Commentary Volume 14 Issue 11 - 2025

Long COVID: A Bane of Previously Infected COVID-19 Patients

Rumi Khajotia*

Consultant Pulmonologist, Department of Internal Medicine, IMU University, Seremban, Malaysia

*Corresponding Author: Rumi Khajotia, Consultant Pulmonologist, Department of Internal Medicine, IMU University, Seremban, Malaysia.
Received: October 06, 2025; Published: October 29, 2025



‘Long COVID’ is also commonly known as ‘Post-COVID-19 Condition’ (PCC) or Post-Acute Sequelae of SARS-CoV-2 infection. This unfortunate condition, which truly is a bane of patients infected previously with the COVID-19 virus, usually results in multisystem symptoms and clinical signs which persist or recur after acute COVID-19 infection. Long COVID may present with clinical features which may be continuous, progressive or of a remitting and relapsing nature, usually setting in about 3 months after the acute infection. While most patients who recover after an acute COVID-19 infection recover fully, a significant percentage (roughly between 10%-30%) develop at least one or more persistent symptom which continues to remain beyond a period of 3 months. The exact prevalence varies depending on the severity of the original infection (and whether the patient is hospitalised or not), presence of comorbidities, age of the patient and vaccination status.

Rumi Khajotia. “Long COVID: A Bane of Previously Infected COVID-19 Patients”. EC Pulmonology and Respiratory Medicine  14.11 (2025): 01-03.